Neurocarrus is developing a novel therapy to treat pain without addiction.
We are a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control. Our first-in-class therapeutic (N-001) is designed to treat the physiological symptoms of pain without invasive surgical procedures or systemically absorbed drugs.
We engineered N-001 for individuals experiencing pain as a result of tissue injury or inflammation as well as patients with acute nerve damage. N-001 is a leading technology in the fight against the prescription opioid abuse and heroin epidemic, which claims the lives of tens of thousands of Americans each year. A safe, non-addictive and effective treatment for pain (a disease burden of over $635 billion in the US*) would have a major impact on human health.
Neurocarrus was founded by prominent research scientists in the field of protein engineering. The company is led by a strong management and advisory team with expertise in business, biotechnology and medicine. To date, we have generated extensive in vitro and in vivo data supporting the efficacy of N-001.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 479 Jessie St, San Francisco,california,united States
- pa****@****rus.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neurocarrus.com
- Keywords
- Minneapolis.
- HQ
- San Francisco, California
Neurocarrus Questions
Neurocarrus's website is neurocarrus.com
Neurocarrus's LinkedIn profile is https://www.linkedin.com/company/neurocarrus
Neurocarrus has
4 employees.
View email and phone details for 4
employees at Neurocarrus.
Neurocarrus's industry is
Biotechnology Research
Neurocarrus's top competitors are
Antibiotic Adjuvant, Inc.,
Power Hero,
Wavecrest Securities,
Iondx Inc.,
Telix Pharmaceuticals Limited,
Mvrix Co., Ltd,
M.zoro Consulting,
Atlas Biotech,
Vybion, Inc.,
Precede Biosciences.
Neurocarrus's support email address is paul@neurocarrus.com
Neurocarrus's categories are Biotechnology Research
Neurocarrus's founding year is 2015
